SB173 amends West Virginia Code to define “abortifacient” and make it unlawful to send, place into commerce, prescribe, or otherwise disseminate such drugs to persons in West Virginia. The bill imposes a felony (3–10 years) for nonlicensed actors, mandates license revocation for licensed medical professionals found to have knowingly and willfully violated the prohibition, and creates a private civil cause of action with statutory damages and injunctive relief for recipients or their family members.
The measure also requires new continuing medical education focused on the alleged dangers of the abortion pill and the efficacy of “abortion pill reversal.” Exemptions are narrow (pharmacies filling lawful in-state prescriptions and certain accidental/harmful outcomes during legitimate medical care), and the bill specifically targets cross‑border prescribing and mail‑order distribution to West Virginia residents — shifting enforcement partly to private litigants and professional licensure bodies, and creating compliance challenges for telemedicine and pharmaceutical supply chains.
At a Glance
What It Does
The bill outlaws knowingly sending, prescribing, placing into commerce, or distributing abortifacients to people in West Virginia, regardless of where the prescriber is located. It makes nonmedical actors guilty of a felony, requires licensing boards to revoke a clinician’s license for knowing violations, and authorizes civil suits with $10,000 statutory damages per abortion plus injunctive relief.
Who It Affects
Out‑of‑state and in‑state prescribers (including telemedicine providers), mail‑order and retail pharmacies, drug distributors and couriers, licensing boards, and patients who seek medication abortion. Courts and defense counsel will also see new private‑party litigation tied to distribution of these drugs.
Why It Matters
SB173 directly targets remote prescribing and mail distribution routes used for medication abortion and creates a private‑enforcement mechanism that does not require a criminal conviction to establish civil liability. That combination changes the compliance calculus for clinicians, pharmacies, and telehealth companies that serve West Virginia residents.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
SB173 begins by setting definitions that narrow what counts as legitimate medical practice and broaden the statutory reach of abortion‑related prohibitions. Key statutory definitions include an intent‑based definition of “abortifacient,” a restrictive medical‑emergency definition that excludes psychological and emotional conditions, and a fixed definition of pregnancy and stages of fetal development.
The bill makes those definitions controlling for the rest of the article, which matters because many enforcement questions turn on whether an act was performed with the requisite intent.
The heart of the bill is a list of prohibited acts: sending an abortifacient into West Virginia by mail or courier; placing such a product into the stream of commerce when the actor knows it will be used in West Virginia; prescribing an abortifacient to a West Virginia resident (the statute explicitly applies irrespective of where the prescriber is located); and disseminating an abortifacient without a lawfully valid prescription. The statutory culpability standard is “knowingly and willfully,” which the bill uses to trigger either criminal penalties for nonlicensed actors or professional discipline for licensed practitioners.Criminal and civil remedies operate in parallel.
Nonlicensed persons who knowingly violate the prohibition face a felony carrying a determinate 3–10 year sentence. Licensed medical professionals who knowingly and willfully violate the ban are subject to mandatory license revocation by their relevant board.
Separately, the bill creates a private civil right of action: a pregnant person who unlawfully receives an abortifacient, or certain family members defined elsewhere in code, may sue the supplier; the statute authorizes injunctive relief and awards $10,000 in damages for each abortion the defendant knowingly and willfully performed or attempted to perform, and it permits establishing liability without an underlying criminal indictment or conviction.The text preserves narrow exceptions: pharmacies fulfilling a valid in‑state prescription are exempt, and physicians providing legitimate medical procedures that unintentionally injure or kill an unborn child are not covered by the prohibition. Finally, SB173 imposes continuing‑education requirements on clinicians: two hours within one year of initial licensure and two hours biennially thereafter, specifically addressing the alleged dangers of the abortion pill and the claimed efficacy of abortion‑pill reversal—topics that the statute elevates as mandatory components of licensing renewal.
The Five Things You Need to Know
The statute makes it a felony (3–10 years) for any nonlicensed person who knowingly and willfully sends, places into commerce, prescribes to, or disseminates an abortifacient to a West Virginia resident.
A licensed medical professional who knowingly and willfully violates the prohibition is subject to mandatory license revocation by the applicable West Virginia licensing board.
The bill creates a private civil cause of action for a pregnant person who unlawfully received an abortifacient, or certain family members, allowing injunctive relief and statutory damages of $10,000 per abortion without requiring a criminal conviction.
Prescribing an abortifacient to a West Virginia resident is prohibited regardless of the prescriber’s physical location, directly targeting out‑of‑state telemedicine and mail‑order prescription models.
Licensed clinicians must complete two hours of CME within a year of initial licensure and two hours biennially thereafter about the 'dangers of the abortion pill' and the 'efficacy of the abortion pill reversal.'.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Definitions that set scope and intent standard
This section supplies the statutory vocabulary: it defines 'abortifacient' as any chemical or drug prescribed or dispensed with the intent of causing an abortion and narrows 'medical emergency' to life‑threatening physical risks (excluding psychological harms). By making these definitions controlling across the article, the bill anchors liability to intent and limits defenses based on broader clinical judgment or coding terms found in medical records.
Prohibited acts — sending, placing into commerce, prescribing, disseminating
Subsection (a) outlines four discrete prohibitions: (1) mailing or couriering abortifacients to persons in West Virginia; (2) placing an abortifacient into the stream of commerce when the actor knows it will be used in West Virginia; (3) prescribing to a West Virginia person regardless of prescriber location; and (4) disseminating an abortifacient without a lawfully valid prescription. The structure targets both physical distribution channels and the act of prescribing, so compliance obligations include verifying patient residence, prescription legitimacy, and knowledge of ultimate use.
Criminal penalties and professional discipline
Subsection (b) separates enforcement by actor type: nonlicensed actors face a mandatory felony term of three to ten years if they knowingly and willfully violate subsection (a); licensed medical professionals are not criminalized here but face board discipline culminating in mandatory license revocation if the board finds a knowing and willful violation. Practically, the provision places criminal risk on distributors and non‑medical actors while converting clinician violations into a licensing proceeding with an absolute remedy (revocation) upon a finding of culpability.
Private civil remedies and narrow exemptions
Subsection (c) permits civil suits by the pregnant person who unlawfully received an abortifacient or by specified family members, bypassing typical wrongful‑death procedural limits. Successful plaintiffs obtain injunctive relief and $10,000 per abortion; the statute emphasizes that a criminal indictment or conviction is not a prerequisite to civil liability. Subsection (d) carves out two explicit exemptions: pharmacies filling a lawful in‑state prescription and physicians whose legitimate medical procedures result in accidental or unintentional fetal injury or death. Those exemptions are limited and will shift how pharmacies and clinicians document prescriptions and medical decision‑making.
Continuing education requirement tied to abortion pill claims
This section mandates that newly licensed clinicians complete two hours of continuing medical education within the first year on the 'dangers' of the abortion pill and the 'efficacy' of abortion‑pill reversal, and then two hours biennially for license renewal. The statutory subject matter and frequency make curriculum content a matter of licensure compliance and create an administrative obligation for boards and providers to approve and track specific CME offerings.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Pregnant individuals (and qualifying family members) who receive abortifacients: they gain an explicit private civil remedy with statutory damages and injunctive relief that can be pursued without a criminal conviction against the supplier.
- In‑state pharmacies filling lawfully valid in‑state prescriptions: the statute exempts pharmacies acting on valid prescriptions, reducing direct criminal exposure for compliant retail pharmacies that verify prescription legitimacy and patient residency.
- West Virginia licensing boards: the bill gives boards a clear statutory obligation and authority to revoke licenses for knowing violations, centralizing professional enforcement and simplifying disciplinary standards for abortion‑related conduct.
Who Bears the Cost
- Out‑of‑state telemedicine providers and prescribers: the law applies regardless of prescriber location, exposing remote clinicians to the risk of state enforcement or civil suits when treating West Virginia residents.
- Mail‑order pharmacies, drug distributors, and courier services: companies that ship abortion medications into West Virginia face felony liability unless they can establish lack of knowledge or claim a valid‑prescription exemption, creating compliance and legal‑risk costs.
- Licensed medical professionals who prescribe or dispense abortifacients: clinicians face mandatory license revocation upon a finding of knowing and willful violation, increasing professional risk and likely prompting defensive practice or withdrawal from treating West Virginia patients.
- Courts and defense counsel: the private‑enforcement regime with statutory damages will increase civil litigation, requiring judicial resources and raising defense costs for entities accused of supplying abortifacients.
Key Issues
The Core Tension
The bill pits the state’s intent to block chemical abortion access and enforce that policy through criminal, civil, and licensure tools against established models of cross‑state telemedicine, mail distribution of prescription drugs, and clinical discretion—forcing a trade‑off between enforcing a residency‑bounded prohibition and preserving access to remote medical care and conventional prescribing practices.
SB173 hinges on intent and knowledge. The core prohibitions are tied to whether an actor 'knows' the abortifacient will be used in West Virginia or 'knowingly and willfully' distributes it, which creates evidentiary and proof burdens that will drive litigation strategy.
Determining where a drug will be used (patient residency, forwarding addresses, VPNs, cross‑border pickup) and proving a supplier’s mental state are fact‑intensive inquiries that will generate pretrial disputes and may chill legitimate cross‑border care.
The private civil remedy raises procedural and policy questions: plaintiffs may establish liability without a criminal conviction, and the $10,000 per‑abortion statutory damage is a blunt instrument that could encourage mass‑claim strategies or settlements irrespective of the underlying medical nuance. The pharmacy exemption is narrow and hinges on 'lawfully valid' in‑state prescriptions, so pharmacies and telehealth vendors will need enhanced identity and residency verification processes; that in turn may restrict access for patients who rely on remote care or who move frequently.
Finally, the CME mandate focuses license renewal on contested clinical claims (dangers of the abortion pill and abortion‑pill reversal) that are medically contested and could create tension between statutory curriculum requirements and established medical evidence or board‑approved CME bodies. Combined with a restricted medical‑emergency definition, these provisions will pressure clinicians to document care conservatively and may incentivize risk‑averse practice patterns that limit available options for patients in emergent or ambiguous clinical scenarios.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.